Schedule 13G ownership disclosure

COGENT BIOSCIENCES INC

Common Stock, $0.001 Par Value · CUSIP: 19240Q201

Event date: 2025-07-07

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Commodore Capital LP

    Shares: 6,408,060.00 · Class: 5.5%

  • Commodore Capital Master LP

    Shares: 6,408,060.00 · Class: 5.5%

  • Robert Egen Atkinson

    Shares: 6,408,060.00 · Class: 5.5%

  • Michael Kramarz

    Shares: 6,408,060.00 · Class: 5.5%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001831942-25-000016
Form type
SCHEDULE 13G
Filer
Cogent Biosciences, Inc.
CIK
CIK 1622229
Filed
Aug 14, 2025
Reporting period
Jul 07, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub